期刊文献+

高分级脑胶质瘤术后精确放疗预后影响因素分析 被引量:16

Prognostic factors of postoperative patients of high-grade gliomas treated with precise radiotherapy
原文传递
导出
摘要 目的:回顾性分析高分级脑胶质瘤(highgradeglioma,HGG)术后精确放疗预后及其影响因素。方法:回顾性分析山西省肿瘤医院放射治疗中心2007—09—2012-03收治的HGG术后患者66例,均行手术治疗,其中肉眼全切36例,次全切除术30例。术后25例行三维适形放疗(three-dimensionalconformalradiationtherapy,3DCRT),41例行调强放疗(intensitymodulatedradiationtherapy,IMRT)。手术至放射治疗的间隔时间8~201d,中位时间35d。放疗总剂量30-78Gy,中位剂量60Gy。Kaplan-Meier法进行生存率的计算,Logrank进行单因素分析,用Cox回归行多因素分析。结果:全组1和3年总生存率分别为74.9%和39.4%,中位生存时间为19.93个月。单因素分析显示,放疗前KPS评分(χ2=4.575,P=0.032)、病理分级(χ2=7.201,P=0.007)、手术切除程度(χ2=18.770,P〈0.001)、年龄(χ2=5.245,P=0.022)和术前癫痫发作(χ2=18.356,P〈0.001)是影响HGG术后放疗生存率的重要因素。多因素分析显示,病理分级(P=0.001)、放疗前KPS评分(P=0.017)、肿瘤切除情况(P〈0.001)和术前癫痫发作(P〈0.001)是影响HGG术后放疗1和3年生存率的独立因素。结论:病理分级低、放疗前KPS评分≥80、手术全切和术前癫痫症状均影响GCG患者术后精确放疗的预后。 [ABSTRACT] OBJECTIVE:To retrospectively analyze the postoperative patients of high-grade gliomas treated with pre- cise radiotherapy. METHODS:The data of 66 patients with HGG treated by postoperative radiotherapy were retrospective- ly analyzed. Thirty-six patients received total resection and 30 patients received subtotal resection. Twenty-five patients were treated with Three-dimensional Conformal Radiation, and 41 patients were treated with Intensity-modulated Radia- tion. The waiting time from operation to radiotherapy was between 8 and 201 days (the median waiting time was 35 days). The radiation dose was between 30 and 78 Gy (the median dose was 60 Gy). The survival rate was caculated by K- M, the Log-rank was used for univariate analysis,and Cox model was used for multivariate analysis. RESULTS: The 1-year and 3-year over all survival rates were 74.9% and 39.4% respectively,and the median survival time was 19.93 months. Univariate analysis showed that KPS score (χ2 = 4.575, P = 0. 032), pathological grade (χ2 = 7.201, P = 0. 007), the ex- tent of surgical resection (χ2= 18. 770,P〈0. 001),age(χ2 = 5. 245,P=0. 022) and epilepsy(χ2= 18. 356,P〈0. 001) were the important factors affecting the survival time. Multivariate analysis showed that pathological grade(P = 0. 001), KPS score (P=0. 017)before radiotherapy,the extent of surgical resection(P〈0. 001) and epilepsy (P〈0. 001) were the independent factors affecting the 1-year or 3-year survival rate of high-grade gliomas treated by postoperative radiothera- py. CONCLUSION: Low pathological grade,KPS score before radiotherapy≥80, total resection and epilepsy before surger- y are better prognostic factors.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2013年第18期1418-1421,共4页 Chinese Journal of Cancer Prevention and Treatment
基金 山西省卫生厅科技攻关计划(200662)
关键词 脑肿瘤 放射疗法 神经胶质瘤 放射疗法 预后因素 回顾性研究 brain neoplasms/radiotherapy glioma/radiotherapy prognostic factor retrospective studies
  • 相关文献

参考文献12

  • 1Colen CB. Shen Y. Ghoddoussi F. et al. Metabolic targeting of ac- tate efflux by malignant glioma inhibits invasiveness and induces necrosis :an invivo study[J]. Neoplasia.Eo l l v l St Z) :620-632.
  • 2王俊杰,王刚,周章明,曾南,梅正平,朱爱萍.神经胶质瘤的治疗研究进展[J].癌症进展,2011,9(1):63-67. 被引量:13
  • 3Anand AK. Chaudhory AR. Aggarwal HN. et al. Survial outcome and neurotoxicity in patients of high-grade gliomas treated with conformal radiation and temozolamide[J].J Cancer Res Ther , 2012.8(1) :50-56.
  • 4顾文栋,裴红蕾.69例脑胶质瘤术后三维适形放射治疗临床分析[J].中国神经肿瘤杂志,2011,9(2):124-127. 被引量:10
  • 5孙增峰,李文良,谷峰,马勇杰.胶质瘤耐药相关机制的研究进展[J].中华肿瘤防治杂志,2011,18(7):551-556. 被引量:13
  • 6van den Bent MJ. Hegi ME. Stupp R. Recent developments in the use of chemotherapy in brain tumours[J]. EurJ Cancer. 2006 .42 (5) :582-588.
  • 7Weller M. FelsbergJ. Hartmann C. et al. Molecular predictors of progression-fre e and overall survival in patients with newly diag?nosed glioblastoma: a prospective translational study of the Ger?man Glioma N.
  • 8Stummer W. Meinel T. Ewelt C. et al. Prospective cohort study of radiotherapy with concomitant and adjuvant temozolomide chemotherapy for glioblastoma patients with no or minimal resid?ual enhancing tumor loa.
  • 9梁永平,马晓东,王宇博.高级别脑胶质瘤手术后联合放化疗疗效观察[J].军医进修学院学报,2011,32(6):557-559. 被引量:9
  • 10李蓉,兰胜民,王宏卫,曹建忠,任淑惠,罗宁,张蕾.低分级脑胶质瘤术后放疗生存分析[J].中华肿瘤防治杂志,2010,17(13):1021-1024. 被引量:9

二级参考文献70

  • 1兰胜民,赵铭,郭汝元,李红卫,张红雨,王宏卫.脑瘤全脑放射治疗致血脑屏障破坏的临床研究[J].中华放射肿瘤学杂志,2004,13(3):245-245. 被引量:11
  • 2葛培林,钟云萍.低级别脑胶质瘤预后分析[J].肿瘤防治研究,2005,32(7):438-439. 被引量:4
  • 3Benesch M Eder HG Sovinz P Raith J Lackner H Moser A Urban C.Residual or recurrent cerebellar low-grade glioma in children after tumor resection: is re-treatment needed? A single center experience from 1983 to 2003[J].中国神经肿瘤杂志,2006,4(3):204-204. 被引量:15
  • 4Louis D N, Ohgaki H, Wiestler O D, et al. The 2007 WHO classification of tumours of the central nervous system[J]. Acta Neuropathol, 2007, 114(2) :97-109.
  • 5Baumert B G, Stupp R. Low grade glioma:a challenge in therapeutic options : the role of radiotherapy[J]. Ann Oncol, 2008, 19(Suppl 7) :217-222.
  • 6Bauman G, Fisher B, Watling C, et al. Adult supratentorial lowgrade glioma: long-term experience at a single institution[J]. Int J Radiat Oncol Biol Phys, 2009,75(5) : 1401-1407.
  • 7Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low grade glioma[J]. J Clin Oncol, 2002, 20(8):2076-2084.
  • 8Smith J S,Chang E F,Lamborn K R,et al. Role of extent resection in the long-term outcome of low-grade hemispheric glioma [J]. J ClinOncol, 2008, 26(8):1338-345.
  • 9Nunez O M, Seol H J, Rutka J T. The role of surgery in the management of intracranial gliomas:Current concepts [J]. Indian J Cancer, 2009, 46(2) :120-126.
  • 10van den Bent M J, Afra D, de-Witte O, et al. Long term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EROTC 22845 random isedtrial[J]. Lancet, 2005, 366(9490): 985-990.

共引文献61

同被引文献164

  • 1Barroso Ribeiro R,Ribeiro Breda E, Fernandes Monteiro E. Prognos tic significance of nodal metastasis in advanced tumors of the larynx and hypopharynx[J]. Acta Otorhinolaryngol Esp, 2012,63 (4) : 292-298.
  • 2Myers EN, Alvi A. Managment of carcinoma of the supraglottic larynx:evolution,current c oncepts and future trends[J]. Lary goseope,1996,106:559-567.
  • 3Spriano G, Piantanida R, Pellini R, et al. Elective treatment of the neck in squamous cell carcinoma of the larynx:clinical experi ence [J]. Head Neck, 2003,25 (2) : 97-102.
  • 4Chone CT, Kohler HF, Magalhfies R, et al. Levels Ⅱ and HI neck dissection for larynx cancer with No neck[J]. Braz J Otorhi nolaryngol, 2012,78 (5) : 59-63.
  • 5Natsugoe S, Nakashima S, Matsumoto M, et al. Biologic and ima- ging diagnosis of lymph node metastasis in esophageal carcino- ma. [J]. J Surg Oncol,2002,81(1) :25-32.
  • 6Vargas R ,R ub-Ha n JA, CJemmer J, et al. Tumor size,depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis[J]. Gynecol Oncol, 2014,133(2) : 216-220.
  • 7Amar A,Rapoport A, Cervantes O. Metdstases cervicais bilater- ais no carcinoma epiderm6ide de cabecae pescoco: tratamento cirflrgico em um ou dois tempos[J]. Rev Bras Otorrinolaringol, 2004,70(1) :42-45.
  • 8Amar A,Chedid HM, Franzi SA, et al. Neck dissection in squa- mous cell carcinoma of the larynx. Indication of elective contra- lateral neck dissection[J]. Braz J Otorhinolaryngol, 2012,78 (2) : 7-10.
  • 9Medina JE, Ferlito A, Robbins KT, et al. Central compartment dissec tion in laryngeal cancer[J]. Head Neck,2011,33(5) :746-752.
  • 10Negm H, Mosleh M, Fathy H, et al. Cytokeratin immunohistochemi- cally detected nodal mierometastases in No laryngeal cancer:impact on the overall occult metastases[J]. Eur Arch Otorhinolaryngol, 2013, 270(3) : 1085-1092.

引证文献16

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部